Leif Bengtsson Selected Research

N- 3- (3- (3- methoxy- 4- oxazol- 5- ylphenyl)ureido)benzylcarbamic acid tetrahydrofuran-3-yl ester

12/2009	Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
10/2007	Phase 2 study of the combination of merimepodib with peginterferon-alpha2b, and ribavirin in nonresponders to previous therapy for chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Leif Bengtsson Research Topics

Disease

5	Infections 06/2014 - 04/2009
4	Chronic Hepatitis C 04/2015 - 10/2007
2	Virus Diseases (Viral Diseases) 04/2015 - 06/2011
2	Anemia 06/2011 - 04/2009
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Disease Progression 01/2018
1	Eczema 02/2013
1	Hepatitis C 02/2013
1	Dermatitis 02/2013
1	Exanthema (Rash) 04/2009
1	Body Weight (Weight, Body) 04/2009
1	Pruritus (Itching) 04/2009
1	Persistent Infection 04/2009

Drug/Important Bio-Agent (IBA)

7	Ribavirin (Virazole)FDA LinkGeneric 04/2015 - 10/2007
7	telaprevirIBA 04/2015 - 04/2009
2	InterferonsIBA 02/2013 - 12/2009
2	peginterferon alfa-2a (Pegasys)FDA Link 06/2011 - 04/2009
2	N- 3- (3- (3- methoxy- 4- oxazol- 5- ylphenyl)ureido)benzylcarbamic acid tetrahydrofuran-3-yl esterIBA 12/2009 - 10/2007
1	ivacaftorIBA 01/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2018
1	Pharmaceutical PreparationsIBA 02/2013
1	RNA (Ribonucleic Acid)IBA 06/2011
1	Interferon alpha-2 (Roferon-A)FDA Link 12/2009
1	Oxidoreductases (Dehydrogenase)IBA 12/2009
1	Inosine Monophosphate (IMP)IBA 12/2009
1	Antiviral Agents (Antivirals)IBA 12/2009

Therapy/Procedure

5	Therapeutics 04/2015 - 10/2007